Mimedx (MDXG) Total Non-Current Liabilities (2010 - 2026)

Mimedx (MDXG) has 17 years of Total Non-Current Liabilities data on file, last reported at $60.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 0.82% year-over-year to $60.6 million; the trailing twelve-month figure through Mar 2026 stood at $60.6 million (up 0.82% YoY), and the FY2025 full-year result was $80.7 million, up 27.29% from the prior year.
• Total Non-Current Liabilities fell to $60.6 million in Q1 2026, from $80.7 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $94.3 million in Q3 2022 to a low of $58.3 million in Q2 2024.
• A 5-year average of $77.2 million and a median of $80.7 million in 2025 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities plunged 37.55% in 2024 and gained 27.29% in 2025, its largest moves.
• Tracing MDXG's Total Non-Current Liabilities over 5 years: stood at $92.2 million in 2022, then climbed by 2.12% to $94.1 million in 2023, then plunged by 32.6% to $63.4 million in 2024, then increased by 27.29% to $80.7 million in 2025, then dropped by 24.88% to $60.6 million in 2026.
• Business Quant data shows MDXG's Total Non-Current Liabilities at $60.6 million in Q1 2026, $80.7 million in Q4 2025, and $74.5 million in Q3 2025.